공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

주입 펌프 및 부속품 시장 : 성장, 동향, COVID-19의 영향, 예측(2021-2026년)

Infusion Pumps and Accessories Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

리서치사 Mordor Intelligence Pvt Ltd
발행일 2021년 03월 상품 코드 390886
페이지 정보 영문
가격
US $ 4,250 ₩ 4,793,000 PDF (Single User License)
US $ 4,750 ₩ 5,357,000 PDF (Team License: Up to 7 Users)
US $ 6,000 ₩ 6,766,000 PDF (Site License)
US $ 7,500 ₩ 8,458,000 PDF (Corporate License)


주입 펌프 및 부속품 시장 : 성장, 동향, COVID-19의 영향, 예측(2021-2026년) Infusion Pumps and Accessories Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
발행일 : 2021년 03월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

주입 펌프는 40년 전에 사용되기 시작한 의료기기이며, 현재는 다양한 주입 펌프가 있고 그 용도는 세계적으로 증가하고 있습니다. 연속 피하 인슐린 투여에서 사용되는 주입 펌프 중에서는 인슐린 펌프가 가장 많이 사용되고 있으며, 특히 미국 등의 선진국에서 사용이 증가하고 있습니다.

세계의 주입 펌프 및 부속품(Infusion Pumps and Accessories) 시장을 조사했으며, 시장 개요, 제품 종류·용도·최종사용자·지역별 시장 규모 추이와 예측, 시장 성장 촉진요인 및 저해요인 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 서론

  • 조사 성과
  • 조사의 전제조건
  • 조사 범위

제2장 조사 방법

제3장 주요 요약

제4장 시장 역학

  • 시장 개요
  • 시장 성장 촉진요인
    • 주입 펌프 도입률 향상
    • 급속한 기술 진보
    • 만성질환 발생률 상승
  • 시장 성장 저해요인
    • 주입 펌프의 높은 가격
    • 주입 펌프에 관한 안전성 문제
  • Five Forces 분석
    • 구매자의 협상력
    • 공급기업의 협상력
    • 신규 진출기업의 위협
    • 대체품의 위협
    • 경쟁 기업간 경쟁 관계

제5장 주입 펌프 및 부속품 세계 시장 : 부문별

  • 제품 종류별
    • 주입 펌프
    • 부속품 및 소모품
  • 용도별
    • 소화기과
    • 당뇨병
    • 관리
    • 혈액과
    • 기타
  • 최종사용자별
    • 병원
    • 외래수술센터
    • 기타
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 중동 및 아프리카
    • 남미

제6장 경쟁 구도

  • 기업 개요
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Becton, Dickinson, and Company
    • CareFusion Corporation
    • F. Hoffmann-la Roche Ltd.
    • Johnson & Johnson
    • Medtronic Inc.
    • Pfizer Inc.
    • Smiths Medical
    • Terumo

제7장 시장 기회 및 향후 동향

LSH 19.07.01

The Infusion Pumps and Accessories Market was valued at USD 9,990 million in 2020 and it is expected to reach USD 13,735 million by 2026, registering a CAGR of 5.4% during the forecast period.

In May 2020, United States Food and Drug Administration (US FDA) issued an umbrella emergency use authorization (EUA) for infusion pumps and infusion pump accessories for use by healthcare providers to treat conditions caused by the Coronavirus Disease 2019 for the controlled infusion of medications, total parenteral nutrition, and other fluid requirements. The US FDA has issued EUAs that have increased the availability of infusion pumps and infusion pump accessories, which are an integral part of the patient treatment during the COVID-19 pandemic. This guideline had a positive impact on the growth of the market in the recent past and is expected to propel at higher growth rates even in the future.

The global infusion pumps and accessories market is primarily driven by the rising incidence of chronic diseases, such as cancer and others, coupled with the rising adoption of these devices, owing to broadening applications of infusion pumps. Currently, infusion pumps are widely used in chemotherapy, diabetes management, and many other applications. The rising prevalence of these diseases, worldwide, is creating ample opportunities for the market to grow. For instance, according to International Diabetes Federation (IDF), in 2019, there were approximately 463 people were living with diabetes, and is estimated that the number is anticipated to grow to 700 million by 2045.

In addition, technological advancements in device technology, and companies' efforts in innovating products to meet the safety and increase the adoption of devices are likely to fuel the market growth. Moreover, the market players in the global infusion pumps and accessories market are actively participating in new product launches against individual disease treatment procedures, geography expansions, and collaborations to improve their market share. One such activity includes the launch of D-mine, a wearable micro-infusion pump, used for the continuous subcutaneous administration of drugs to treat Parkinson's disease, by EVER Pharma in July 2019. Currently, there are several various types of infusion pumps available; one of them, which has gained huge popularity for continuous subcutaneous insulin infusion, is the insulin infusion pump.

A significant rise in the usage of insulin pump was observed in the past decade and as per the article published by American Diabetes Association in 2018, approximately 30-40% of patients with Type 1 diabetes and a growing number of insulin-requiring patients with Type 2 diabetes are dependent on infusion pump and sensor technology. Hence, owing to all the aforementioned factors the market is anticipated to grow at high growth rates.

Key Market Trends

Volumetric Infusion Pumps are Believed to Witness Largest Market Share in the Forecast Period

Volumetric infusion pumps have a wide range of applications in disease management as well as parenteral nutrition, owing to which the market value for volumetric is the highest, as compared to the markets for other pumps. The safety, accuracy, and simplicity of the infusion pumps in the treatment of many therapeutic areas contribute to the high demand for these pumps.

Currently, the volumetric infusion pump segment is driven by its wide applications, advantages, and increasing use and growing product launches in the developing as well in the developed countries. In 2019, Mindray launched its new BeneFusion 5 Series infusion pump system to redefine the safe Infusion through various safety features. The launch of these technologically advanced products is the major reason propelling the market demand. Moreover, the demand for these pumps is expected to increase globally, especially in the Asia-Pacific and South American countries, owing to their increasing popularity and rising focus of governments on the healthcare infrastructure.

The increasing chronic disease population is also expected to boost the demand for these pumps, and therefore, the market growth in the future. Moreover, more people are expected to be able to opt for the use of volumetric pumps in-home healthcare as s the socio-economic prospect of developing countries is improving which is acting as a driving factor for the market growth. The major players are also focusing on leveraging the opportunities of home infusion. For instance, in 2018, Shift signed a collaboration agreement with New England Life Care (NELC), to expand its footprint in the home and alternate site infusion market

North America is Expected to Dominate the Market Over the Forecast Period

North America is expected to hold the major share of the intravenous infusion pumps and accessories market. The growth of the market is driven by the rapid adoption of technologically advanced products by patients and physicians both for regular treatment of chronic disease conditions. The burden of several chronic diseases is increasing at surging rates. The latest 2019 report from National Health Council has stated that chronic diseases affect around 133 million Americans, representing more than 40% of the total population of this country. It was estimated by the same report that by 2020, around 157 million Americans may be having chronic conditions with 81 million having multiple conditions. The current growth of the market can is also driven by the rapid adoption of home healthcare infusion pump therapies. Also, the Institute for Safe Medication Practices Canada (ISMP) conducts surveys on infusion pumps and their usage in the hospitals. By conducting surveys, ISMP understands the issues and concerns and suggests the safe utilization of infusion pumps to the hospitals in Canada. All these initiatives by the government increase the procurement of these pumps and accessories in hospitals.

Also, for the past few decades, the duration of inpatient stays has increased resulting in increased demand for infusion pumps for these patients. According to the American Hospital Association in 2018, over 36,353,946 hospital admissions were registered in the United States. Hence, owing to all the aforementioned factors, the market is anticipated to grow exponentially.

Competitive Landscape

The market for infusion pumps and accessories is highly competitive and consists of global as well as local players. Due to technological advancements, many small and mid-sized companies are focusing on market penetration to grab the market share. Some of the key global players of this market are B. Braun Melsungen AG, Becton, Dickinson and Company, Medtronic Plc., Smiths Medical Inc., and Terumo Corporation.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Adoption Rate of Infusion Pumps
    • 4.2.2 Rising Incidences of Chronic Disease
  • 4.3 Market Restraints
    • 4.3.1 High Price of Infusion Pumps
    • 4.3.2 Safety Issues Associated with Infusion Pumps
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Infusion Pump Types
      • 5.1.1.1 Syringe Infusion Pumps
      • 5.1.1.2 Volumetric Infusion Pumps
      • 5.1.1.3 Elastomeric Infusion Pumps
      • 5.1.1.4 Insulin Infusion Pumps
      • 5.1.1.5 Enteral Infusion Pumps
      • 5.1.1.6 Others
    • 5.1.2 Accessories/Disposables
  • 5.2 By Application
    • 5.2.1 Gastroenterology
    • 5.2.2 Diabetes Management
    • 5.2.3 Hematology
    • 5.2.4 Others
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgery Center
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States (By Product Type, By Application and By End User)
      • 5.4.1.2 Canada (By Product Type, By Application and By End User)
      • 5.4.1.3 Mexico (By Product Type, By Application and By End User)
    • 5.4.2 Europe
      • 5.4.2.1 Germany (By Product Type, By Application and By End User)
      • 5.4.2.2 United Kingdom (By Product Type, By Application and By End User)
      • 5.4.2.3 France (By Product Type, By Application and By End User)
      • 5.4.2.4 Italy (By Product Type, By Application and By End User)
      • 5.4.2.5 Spain (By Product Type, By Application and By End User)
      • 5.4.2.6 Rest of Europe (By Product Type, By Application and By End User)
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China (By Product Type, By Application and By End User)
      • 5.4.3.2 Japan (By Product Type, By Application and By End User)
      • 5.4.3.3 India (By Product Type, By Application and By End User)
      • 5.4.3.4 Australia (By Product Type, By Application and By End User)
      • 5.4.3.5 South Korea (By Product Type, By Application and By End User)
      • 5.4.3.6 Rest of Asia-Pacific (By Product Type, By Application and By End User)
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC (By Product Type, By Application and By End User)
      • 5.4.4.2 South Africa (By Product Type, By Application and By End User)
      • 5.4.4.3 Rest of Middle East and Africa (By Product Type, By Application and By End User)
    • 5.4.5 South America
      • 5.4.5.1 Brazil (By Product Type, By Application and By End User)
      • 5.4.5.2 Argentina (By Product Type, By Application and By End User)
      • 5.4.5.3 Rest of South America (By Product Type, By Application and By End User)

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Baxter International Inc.
    • 6.1.2 Becton, Dickinson and Company
    • 6.1.3 Braun Melsungen AG
    • 6.1.4 CareFusion Corporation
    • 6.1.5 Eli Lilly and Company
    • 6.1.6 F. Hoffmann-la Roche Ltd
    • 6.1.7 Fresenius Kabi
    • 6.1.8 ICU Medical Inc.
    • 6.1.9 Johnson & Johnson
    • 6.1.10 Medtronic Inc.
    • 6.1.11 Nipro Corporation
    • 6.1.12 Option Care Health Inc.
    • 6.1.13 Pfizer Inc.
    • 6.1.14 Smiths Medical
    • 6.1.15 Terumo Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top
전화 문의
F A Q